Rockefeller Capital Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Rockefeller Capital Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,000	Closed	-$215K	–	4198
2022 Q4	$215K	Sell	8,000 -42,000	-84%	-$1.1M	﹤0.01%	1634
2022 Q3	$898K	Sell	50,000 -12,500	-20%	-$200K	﹤0.01%	1052
2022 Q2	$776K	Sell	62,500 -4,500	-7%	-$49.7K	﹤0.01%	1082
2022 Q1	$892K	Buy	67,000 +17,000	+34%	+$228K	﹤0.01%	1091
2021 Q4	$778K	Buy	50,000 +18,000	+56%	+$344K	﹤0.01%	1143
2021 Q3	$718K	Sell	32,000 -2,500	-7%	-$54.9K	﹤0.01%	1126
2021 Q2	$785K	Buy	34,500 +9,600	+39%	+$202K	﹤0.01%	1020
2021 Q1	$512K	Buy	+24,900	New	+$567K	﹤0.01%	1013

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rockefeller Capital Management's MYOV Position: Q1 2023 in Review

Rockefeller Capital Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 8,000 shares — an estimated $215K sold.

Rockefeller Capital Management first reported a position in MYOV in Q1 2021 and held it in 8 quarters. The position peaked at $898K in Q3 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Rockefeller Capital Management reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Rockefeller Capital Management sold 8,000 Myovant Sciences Ltd. shares in Q1 2023, an estimated $215K.
Rockefeller Capital Management first reported a position in Myovant Sciences Ltd. in Q1 2021 and held it in 8 quarters.
Rockefeller Capital Management's Myovant Sciences Ltd. position peaked at $898K in Q3 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Rockefeller Capital Management's 13F filing for Q1 2023, filed 16 May 2023.